TGFB1 and diabetic cardiomyopathy: Supplementation of resveratrol exhibited an anti-proliferative effect on CFs via blocking the ROS/ERK pathway and attenuated fibroblasts-myofibroblast transition via inhibiting the ROS/ERK/TGF-β/periostin pathway in STZ-induced diabetic cardiomyopathy (Wu et al., 2016).